|
J Biol Chem, Vol. 274, Issue 39, 27914-27924, September 24, 1999
Y Receptor-mediated Induction of CD63 Transcripts, a Tetraspanin
Determined To Be Necessary for Differentiation of the Intestinal
Epithelial Cell Line, hBRIE 380i Cells*
Gunnel
Halldén,
Margono
Hadi,
Hong T.
Hong, and
Gregory W.
Aponte
From the Department of Nutritional Sciences, University of
California, Berkeley, California 94720-3104
 |
ABSTRACT |
Peptide YY (PYY) and neuropeptide Y (NPY) are
peptides that coordinate intestinal activities in response to luminal
and neuronal signals. In this study, using the rat hybrid small
intestinal epithelial cell line, hBRIE 380i cells, we demonstrated that
PYY- and NPY-induced rearrangement of actin filaments may be in part through a Y1 and/or a nonneuronal Y2 receptor, which were cloned from both the intestinal mucosa and the hBRIE 380i cells. A number of
PYY/NPY-responsive genes were also identified by subtractive hybridization of the hBRIE 380i cells in the presence or absence of a
6-h treatment with PYY. Several of these genes coded for proteins
associated with the cell cytoskeleton or extracellular matrix. One of
these proteins was the transmembrane-4 superfamily protein CD63,
previously shown to associate with 1-integrin and implicated in cell adhesion. CD63 immunoreactivity, using antibody to
the extracellular domain, was highest in the differentiated cell
clusters of the hBRIE 380i cells. The hBRIE 380i cells transfected with
antisense CD63 cDNA lost these differentiated clusters. These studies suggest a new role for NPY and PYY in modulating
differentiation through cytoskeletal associated proteins.
 |
INTRODUCTION |
Regulatory peptides common to the intestine and nerves (neuro-gut
regulatory peptides) are unique chemical mediators released from
receptosecretory and/or neurosecretory cells having multiple biological
actions. These peptides can act as neurotransmitters, neurocrine,
endocrine, or paracrine agents and share a common function in the
coordination of intestinal activities in response to luminal signals or
signals originating from peripheral tissues. Despite the range of
diversity of their biological effects, there is one recurring
biological observation that seems to link many of these peptides, their
ability to act as factors affecting growth or differentiation of the
intestinal mucosa. Differentiation and regulation of growth of complex
tissues, such as the intestine, are not only determined by growth
factors but also by intracellular signals generated by the interactions
between cells and their extracellular matrix
(ECM)1 (1). In intestinal
epithelial cells, part of the ECM occurs in the form of a basement
membrane that provides these cells with positional information and
signals that initiate the organization of intracellular structure and
cellular behavior. A factor probably important for the positional cues
for differentiation in the intestinal mucosa is the potential link
between the ECM of the lamina propria and the process of cellular
migration from crypt to villus. Although over the past years there have
been studies on the growth effects for specific peptides such as
cholecystokinin (2), bombesin (3), vasopressin, gastrin (4, 5), and
peptide YY (PYY) (6), to name a few, the contribution of these peptides
to intestinal differentiation remains relatively unexplored. Such
investigations were limited in the past primarily due to the lack of an
appropriate cell culture model that mimicked some of the critical
complex cell to cell interactions of the intestine.
To investigate the actions of regulatory peptides on mucosal cell
differentiation, we have utilized intestinal cell lines developed by
somatic cell hybridization (7). We have characterized one of these cell
lines extensively, the Berkeley rat small intestinal epithelial cell
hybrid (hBRIE 380i cells). These cells retain many characteristics of
the enterocyte in situ including the formation of a
nonreplicating polarized differentiated subpopulation of cells derived
from a replicating progenitor-like cell population and expression of
intestine specific structures, proteins, and receptors (7-10). To
date, these are the only small intestinal epithelial cell lines that
are not of embryonic origin that differentiate. A great advantage of
these cells is that they develop a differentiated phenotype only under
suitable hormonal and substratum conditions. The hBRIE 380i cells can
therefore be used to dissect the mechanism(s) by which regulatory
peptides and the basement membrane interact to regulate cell growth
and/or differentiation.
We previously reported that a 6-h treatment of the hBRIE 380i cells
with PYY results in an increase in intestinal fatty acid binding
protein (I-FABP) transcripts only in the differentiated nonproliferating cell population (9). Because I-FABP has been well
established as a differentiation-dependent protein
expressed only in the mature intestinal mucosa (11, 12) and has often been used by others as a marker of intestinal cell differentiation (13), we suspected that PYY or NPY could have more general effects on
differentiation. We presently report that both PYY and NPY stimulated
an increase in actin stress fiber assembly in the hBRIE 380i cells, but
only NPY appeared to initiate the formation of membrane ruffling. These
data indicate that more than one receptor and effector system could be
activated in response to NPY/PYY in these cells. Previous examination
of PYY/NPY binding sites on hBRIE 380i cells has revealed receptors on
both the nondifferentiated and differentiated populations of hBRIE 380i
cells (9). In the current studies, we have cloned two receptors from
the hBRIE 380i cells and rat intestinal epithelial cells that bind NPY
and PYY. One is the Y1 receptor, and the other is a peripheral Y2 receptor found outside of nerves.
Regulation of differentiation of intestinal epithelia by regulatory
peptides such as PYY and NPY may not only be by multiple receptor
pathways but also dependent on interaction of the cell to the
surrounding stroma or ECM. To determine gene-specific responses in
hBRIE 380i cells to NPY and PYY that were also dependent on the cell
basement membrane or cytoskeletal organization, subtractive hybridization was performed on hBRIE 380i cells grown on collagen gel
matrix and exposed to PYY for 6 h. A number of genes were isolated
that code for cytoskeletal related proteins in other tissues and
species, such as the transmembrane-4 superfamily protein (TM4SF or
tetraspanin) CD63. We have verified that PYY induces the induction of
CD63 mRNA levels in the hBRIE 380i cells and the presence of CD63
transcripts in the intestinal mucosa. Among its putative actions in
other cell types, CD63 is thought to be part of a protein complex that
binds integrin and participates in the processes of cell motility,
adhesion, and differentiation (14, 15). We present data demonstrating
that hBRIE 380i cells transfected with CD63 antisense cDNA fail to
undergo differentiation. In the present study, we propose a mechanism
whereby neuro-gut regulatory peptides can affect mucosal cell
differentiation through the regulation of cytoskeletal-extracellular
matrix interactions by modulation of the tetraspanin CD63.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture Conditions--
A subclone of the Berkeley rat
intestinal epithelial hybrid cell line (hBRIE 380 cells) expressing
PYY/NPY binding sites and the I-FABP, the hBRIE 380i cells, was used in
the present study (7-9). Culture conditions were as described
previously (9). Briefly, the hBRIE 380i cells were maintained in
Iscove's modified Dulbecco's medium (IMDM) (Life Technologies, Inc.)
supplemented with 10% bovine calf serum (BCS) (Hyclone Labs, Logan,
UT), 100 units/ml penicillin, and 100 units/ml streptomycin (Life
Technologies) in T75 flasks (Corning Glass) coated with soft collagen
type I gels, prepared from rat tails as described previously (8, 9) and
kept in an atmosphere of 5% CO2 and 95% air at 37 °C.
The hBRIE 380i cells were grown on the collagen gels to confluency in
the presence of IMDM containing 10% BCS. Experimental conditions were
initiated on day 7 of confluency (unless otherwise stated) by replacing
the normal culture medium with limiting medium (IMDM containing 0.1%
BCS and 4 µg/ml transferrin) with or without the addition of 100 nM PYY or NPY (human sequences; American Peptide Company
Inc., Sunnyvale, CA) as described previously (8, 9). Cells were treated
with the peptides for 6 h prior to Northern analysis and
subtractive hybridization.
Cell lines used for the cloning and analysis of the Y receptors were
the hBRIE 380i cells (8, 9), the Berkeley rat intestinal epithelial 291 cells (BRIE 291) (7), and rat adrenal pheochromocytoma (PC)-12 cells
(American Type Culture Collection, Manassas, VA). The cells were grown
on tissue culture-treated plastic in T25 flasks or on collagen type I
gels under similar culture conditions as described above. Total RNA was
isolated from proliferating and postconfluent cells for analysis by
RT-PCR.
Subtractive Hybridization--
Poly(A)+ RNA isolated
from the hBRIE 380i cells treated with or without 100 nM
PYY for 6 h in 0.1% BCS in IMDM was used as starting material in
the subtractive hybridization reaction (PCR-select cDNA subtraction
kit; CLONTECH, Palo Alto, CA). Total RNA was isolated from the cells by a method previously described (16). A pure,
enriched poly(A)+ RNA fraction was prepared by absorption
of total RNA to oligo(dT) cellulose (Stratagene, La Jolla, CA) in 10 mM Tris-HCl, pH 7.4, containing 0.5 M NaCl, 1 mM EDTA, and 0.5% SDS for 2 h at 24 °C. The
cellulose column was then washed with the same buffer containing 0.1%
SDS. Bound poly(A)+ RNA was eluted by the addition of 10 mM Tris-HCl, pH 7.4, containing 1 mM EDTA and
0.1% SDS. The absorption and elution steps were repeated three times
until at least 90% of the rRNA was removed, as determined by agarose
gel electrophoresis. The purified poly(A)+ fraction was
further concentrated by ethanol precipitation and quantitated by
absorption at 260 nm.
In a typical subtraction experiment, 2 µg of the highly purified
poly(A)+ RNA was used for first strand cDNA synthesis,
and a trace amount of [ -32P]dCTP (2 µCi) (NEN Life
Science Products) was added to the reaction to monitor progress of
synthesis. The synthesized cDNAs were digested with
RsaI, ligated to specific adaptors, followed by two rounds of hybridizations according to the manufacturer's instruction (CLONTECH). Two subtractive libraries were
constructed using PCR amplification and T/A cloning, corresponding to
PYY-induced and -repressed mRNAs. Subtracted cDNAs from the
induced and repressed hybridization reactions were labeled with
[ -32P]dCTP by the random primed method (Promega,
Madison, WI) and used as probes to differentially screen the libraries.
Library construction and screening were as described previously, using standard protocols (17). After two subsequent screenings of each
library, positive clones were selected (i.e. clones from the
PYY-induced library that specifically hybridized with labeled cDNAs
from the induced hybridization reaction but not with cDNAs representing the repressed library), sequenced (DNA Sequencing Facility, UC Berkeley), and compared with known sequences in the GenBankTM sequence data base through the National Center
for Biotechnology Information (NCBI, Bethesda, MD) using the Basic
Logarithm Alignment Program (BLAST). Clones whose sequences
corresponded to those of genes coding for proteins involved in cell
growth and/or association with the cytoskeleton were selected for
further studies.
Northern Analysis--
Dispersed intestinal epithelial cells
were prepared and isolated from rat small intestine as described
previously (7). Total RNA was isolated from the intestinal epithelial
cells and the hBRIE 380i cells by previously described methods (8, 16). Poly(A)+ RNA was isolated from total RNA as described above
for subtractive hybridization using an oligo(dT) cellulose column.
Total RNA (30 µg/lane) and poly(A)+ RNA (6-10 µg/lane)
were separated on denaturing agarose gels, transferred to nylon
membranes (Micron Separations Inc., Westborough, MA), and hybridized to
[ -32P]dCTP-labeled probes according to our standard
methods (8). Control probes were synthesized from human cDNA
fragments for -actin (1.8 kb) (CLONTECH) and
glyceraldehyde-3-phosphate dehydrogenase (1.1 kb)
(CLONTECH) and used in each analysis. To identify
the CD63 mRNA, a probe corresponding to the extracellular domain of rat CD63 (18) was used in the hybridization reaction. This probe was
synthesized from a template derived by PCR using primers specific for
codons 104-109 and 197-202 of the rat CD63 cDNA (18). To verify
the identified CD63 transcripts, another CD63 cDNA probe was
synthesized from 878 bp of the mouse CD63 cDNA including the 714-bp
coding region (19) obtained from an expressed sequence tag (EST) clone
(GenBankTM accession number AA097083). A cDNA probe for
clusterin was synthesized using a 1-kb mouse EST cDNA clone
(accession number AA038369), spanning codons 306-420 (20), as a
template. Detection of the tumor-associated membrane protein (TMP) was
by using a 1-kb mouse EST cDNA clone (accession number AA272263)
that included nucleotides 2145-2601 (21) as a template for the
cDNA probe. To identify the anillin-like protein, an 800-bp
fragment was amplified by RT-PCR from the hBRIE 380i cells using
primers based on the cloned and sequenced cDNA identified by
subtractive hybridization and used as a template for the labeled probe.
This 800-bp fragment includes a region similar to the proposed third nuclear translocation domain of anillin (22). Detection of
1-integrin was by using a cDNA probe corresponding
to codons 1-203 of the previously published rat cDNA sequence (23)
synthesized from a template derived by RT-PCR using the conditions
described below (see RT-PCR methods). Autoradiograms were developed
after 20-48 h of exposure, and relative changes in message levels were
normalized to -actin or glyceraldehyde-3-phosphate dehydrogenase
used as controls.
Cytochemical Localization of Actin Filaments--
The hBRIE 380i
cells were grown in the presence of 10% BCS in IMDM on dry
collagen-coated tissue culture dishes. Prior to confluency, the cells
were treated with 100 nM PYY or NPY for 30 min in limiting
media (0.1% BCS in IMDM). Cells were fixed in 4% paraformaldehyde in
phosphate-buffered saline for 30 min at 4 °C, washed in 50 mM Tris-HCl, pH 8.0, permeabilized, and stained for F-actin
by incubation with a mixture of lysolecithin and tetramethyl rhodamine
isothiocyanate/phalloidin (Sigma) for 10 min as described previously
(9, 24). Reorganization of actin filaments was visualized using a Nikon
Optiphot microscope with a × 20 objective lens, and images were
captured and recorded using a digital charged coupled device (CCD) Sony
DK5000 camera (Sony Corp., Tokyo, Japan).
Construction and Selection of CD63 Antisense and Sense hBRIE 380i
Cell Clones--
CD63 cDNA corresponding to the complete coding
region (nucleotides 1-714) (19) was synthesized from the previously
sequenced mouse CD63 EST cDNA (see above). Primers for PCR
amplification were constructed to nucleotides 1-26 and 688-714 of the
CD63 coding region with the addition of restriction enzyme sites for
AflII and BamHI for directional insertion into a
pcDNA6/V5-His A vector (Invitrogen, Carlsbad, CA) that confers
resistance to blasticidin S (Invitrogen). The CD63 cDNA inserts
were constructed so that either the sense or antisense sequence would
be transcribed. Plasmids containing either
CD63-antisense-pcDNA6/V5-His A or CD63-sense-pcDNA6/V5-His A
constructs or the intact pcDNA6/V5-His A plasmid were stably transfected into the hBRIE 380i cells using the calcium phosphate method previously described (7). One day prior to transfection, the
hBRIE 380i cells were seeded at 0.5 × 106 cells/60-mm
tissue culture plate in normal culture medium (IMDM supplemented with
10% BCS, penicillin, and streptomycin as described above). Twenty-four
h after transfection, selection of positive hBRIE clones containing the
plasmid constructs was by the addition of selective medium; 10% BCS in
IMDM containing 10 µg/ml blasticidin S. The conditions for selection
by blasticidin had previously been optimized by determining the
survival rate of untransfected hBRIE 380i cells for various lengths of
time at different concentrations of the antibiotic. No untransfected
hBRIE cells survived more than 4 days in selective medium containing 10 µg/ml blasticidin S.
Selection of cell clones in blasticidin continued for 6 days until no
surviving cells were present in control plates (untransfected hBRIE
380i cells) and were further subcloned. Cells expressing the CD63 sense
(hBRIE 380iCD63+s) and antisense (hBRIE
380iCD63-as) RNA were identified by RT-PCR, using primers
directed to codons 5-11 (CP1) and 197-202 according to the rat CD63
cDNA sequence (18), resulting in the amplification of a 594-bp
cDNA fragment. Antisense and sense clones for further studies were
selected by determining the amount of decrease or increase in CD63
mRNA levels respectively, when compared with untransfected hBRIE
380i cells after normalization to rat -actin, as described below for
the Y receptors.
Generation of Antisera and Immunocytochemistry--
For
immunocytochemical localization of CD63, antisera were generated in
guinea pigs using the extracellular domain of recombinant CD63 (CD63ex)
corresponding to amino acids 104-202 of the published rat protein
sequence (18). A glutathione S-transferase fusion protein
was prepared after cloning the CD63ex cDNA from the hBRIE 380i
cells, generated by RT-PCR using primers corresponding to codons
104-109 and 197-202 (18), into a pGEX-2T expression vector (Amersham
Pharmacia Biotech). Fusion protein isolation, purification, and
antisera generation were as described previously (9). Soluble fractions
of glutathione S-transferase-CD63ex and glutathione S-transferase expressing Escherichia coli BL21
were prepared and used for screening of the antisera by immunoblotting
as described previously (8, 9). Two CD63-specific polyclonal antibodies were generated, GpAb4120ex and GpAb1120ex, and used in the
immunocytochemical localization studies in the hBRIE cells. Specificity
for CD63 was determined by preadsorbing the antisera at a final
dilution of 1:200 with recombinant CD63, in concentrations ranging from 0.1 ng/µl to 1.0 µg/µl protein. GpAb4120ex was most sensitive to
the ligand, with staining blocked at 25 ng/µl. Cells were either fixed and examined as a whole preparation in the tissue culture flask
or as dispersed cells placed on slides by cytospinning (Shandon Southern Products, Sewickley, PA) and immunostained using fluorescein isothiocyanate as the flourophore, by previously described methods (8,
9). All microscopy was performed using a Nikon Optiphot (Nikon Corp.,
Tokyo, Japan), and images were captured using a Sony DK5000 CCD camera.
Cloning and RT-PCR--
The general conditions for RT-PCR
analysis were as follows. One µg of total RNA was used except when
stated otherwise. RNA was denatured at 70 °C for 10 min, followed by
incubation on ice for 5 min, and then reversed transcribed using 200 units of murine moloney leukemia virus reverse transcriptase (Life
Technologies) in a 20-µl reaction mixture containing 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 1 mM dNTPs, 20 units of RNasin (Promega), and 40 pmol of an
antisense primer for 1 h at 37 °C. Aliquots of 1 µl of the
reaction mixture were then subjected to PCR using 1-2.5 units of
Taq DNA polymerase (Promega) in a 50-µl reaction mixture
containing 10 mM Tris-HCl, pH 9.0, 50 mM KCl,
1.5 mM MgCl2, 0.1% Triton X-100, 200 µM dNTPs, and 1 pmol each of the sense and antisense
primers. The sense and antisense primers used in the RT-PCR, and the
specific temperature conditions for the PCR are described below. Care
was taken to test for possible genomic DNA contamination in the PCR.
For each RT-PCR, controls were included in which the reverse
transcriptase and the cDNA were substituted with water. The
amplified fragments were detected under UV light after size separation
by 1% agarose gel electrophoresis and staining with ethidium bromide.
For identification of 1-integrin in the hBRIE 380i
cells, RT was performed using oligo(dT)27. The PCR primers
corresponded to regions between 4 nucleotides before the start codon
and the sixth codon (5'-AAAGATGAATTTGCAACTGG-3') and between the 197th and 203rd codons (5'-TAGCTTTGCTGGTGTTGTAC-3') of rat
1-integrin (23). The PCR was for 30 cycles under the
following conditions: denaturation at 94 °C for 0.5 min, annealing
at 58 °C for 0.5 min, and extension at 72 °C for 0.5 min. For
verification, the PCR mixture was then subjected to buffer exchange
using a MicroSpin S-200 HR column (Amersham Pharmacia Biotech) followed
by restriction enzyme digestion of the 613-bp amplified cDNA
fragment with PvuII and HindIII (Promega)
separately. This fragment was used as a template for labeling of the
1-integrin cDNA used in the Northern analysis.
The RT for the identification of Y1 receptor in hBRIE 380i cells was
done using 5 µg of poly(A)+ RNA and primer Y1P2
(5'-ACRCAIGTISWIRYCATIGC-3'), designed for codons 308-314 within the
seventh transmembrane region (TM) (25, 26). The PCR primers were Y1P1
(5'-AACARAARGAGATGAGRAATGT-3'), corresponding to codons 66-73 (between
TM1 and TM2), and Y1P2, which were designed to be specific for the Y1
receptor based on the rat cDNA sequence with the human Y1 sequence
taken into consideration (25, 26). PCR was performed for 35 cycles
under the following conditions: denaturation at 94 °C for 0.5 min;
annealing at 62 °C for 1 min (five cycles), at 60 °C (15 cycles),
and at 58 °C (15 cycles); and extension at 68 °C for 3 min. The
resulting 745-bp amplified fragment was cloned into pGEM-T vector
(Promega) and sequenced. To clone the entire coding sequence of Y1
receptor cDNA, RT was performed on the RNA from hBRIE 380i cells,
and the intestine using primer Y1P4 (5'-TCAGATTTTTTCATTGTCATTCATAC-3') spanning codon 341 to the stop codon, followed by PCR using primers Y1P3 (5'-ATGAACTCAACTCTGTTCTCCAGG-3'), corresponding to codons 1-8,
and Y1P4 (26). The conditions for the PCR were as follows: denaturation
at 94 °C for 0.5 min; annealing at 62 °C for 0.5 min (five
cycles), at 60 °C (15 cycles), and at 58 °C (15 cycles); and
extension at 72 °C for 1.5 min. The resulting 1149-bp cDNA was
cloned into pGEM-T vector and sequenced.
To identify Y2 receptor in hBRIE 380i cells, 5 µg of
poly(A)+ RNA was reverse transcribed using primer Y2P2
(5'-TARTTISWRTTCATCCAICC-3') designed for codons 326-332, followed by
PCR using primers Y2P1 (5'-ATGGGIGARTGGAAAATGGG-3'), spanning codons
81-87 in TM3, and Y2P2. The primers were designed based on the human
neuroblastoma (27) and mouse brain Y2 cDNA sequences (28). PCR was
performed for 35 cycles under the following conditions: denaturation at 94 °C for 0.5 min; annealing at 62 °C for 1 min (five cycles), at
60 °C (15 cycles), and at 58 °C (15 cycles); and extension at
68 °C for 3 min. The resulting 659-bp amplified fragment was cloned
into pGEM-T vector and sequenced. To clone the full coding sequence of
Y2 receptor cDNA, RT was performed on the RNA from hBRIE 380i cells
and the intestine using primer Y2P4
(5'-TTACACATTGGTAGCCTCNGARAAAGAG-3'), designed for the last nine codons
including the stop codon, followed by PCR using primers Y2P3
(5'-ATGGGYCCRRTAGGTGCAGAG-3'), corresponding to codons 1-7, and Y2P4
(27, 28). The conditions for the PCR were as follows: denaturation at
94 °C for 0.5 min; annealing at 62 °C for 0.5 min (five cycles),
annealing at 60 °C (15 cycles), and annealing at 58 °C (15 cycles); and extension at 72 °C for 1.5 min. The resulting 1146-bp
cDNA was cloned into pGEM-T vector and sequenced.
To determine the presence of the Y2 and Y1 receptors, total RNA from
the hBRIE 380i, BRIE 291, PC12 cells, rat small intestinal epithelial
cells, and rat cerebral cortex was isolated as described previously
(16) and was reversed transcribed using oligo(dT)27. Aliquots of 1 µl of the reaction mixture were then subjected to PCR
to amplify an 811-bp cDNA fragment of rat -actin (29) and a
947-bp cDNA of the Y2 receptor spanning the start codon and TM7
(27, 28) or a 407-bp cDNA of the Y1 receptor spanning codon 248 to
the stop codon (25, 26). The primers used for rat -actin
corresponded to regions between 54 and 35 nucleotides before the start
codon (5'-TACAACCTCCTTGCAGCTCC-3') and between codons 246 and 252 (5'-TCATTGCCGATAGTGATGAC-3') (29). The primers used for the Y2 receptor
were Y2P3 and Y2P5 (5'-ATGTGGAACACGGTGAAGATGAGTTTGTAC-3'); primers used
for the Y1 receptor were Y1P4 and Y1P5 (5'-GGGACAGTAAGTACAGGTCC-3'). The PCR was under the conditions of varying annealing temperature as
follows: denaturation at 94 °C for 0.5 min; 62 °C for 0.5 min (1 cycle), 60 °C (5 cycles), 58 °C (5 cycles), and 55 °C (30 cycles); and extension at 72 °C for 1 min.
The identification of full-length intestinal CD63 mRNA in the hBRIE
380i cells by RT-PCR was as follows. RNA from the hBRIE 380i cell line
was reversed transcribed either using oligo(dT)27 to
capture the 3'-end of the message (3'-RACE), or using primer CP2
(5'-AAACACATAGCCAGCAATGG-3'), corresponding to codons 101-107 of the
rat cDNA (18), to capture the 5'-end of the transcript (5'-RACE).
One µl of the reaction mixture for the 3'-RACE was then subjected to
PCR using primer CP1 (5'-GAGGAATGAAGTGTGTCAAG-3') corresponding to
codons 5-11 (18), and a tailed oligo(dT) primer (5'-GTCGACGCGT27-3') under the following conditions:
denaturation at 94 °C for 0.5 min, annealing at 58 °C for 0.5 min, and extension at 72 °C for 1 min, for a total of 35 cycles. The
reaction mixture for 5'-RACE was incubated at 70 °C for 15 min
followed by incubation at 37 °C for 30 min in the presence of 1 unit
of RNase H and 1 µg of RNase A. The buffer was subsequently exchanged
with water by three consecutive dilutions and concentrations in a
Microcon-100 microconcentrator (Amicon, Beverly, MA). The cDNA was
tailed with poly(dC) in a 20-µl reaction mixture containing 10 mM Tris acetate, pH 7.5, 10 mM magnesium
acetate, 50 mM potassium acetate, 10 µM dCTP,
and 18 units of terminal deoxynucleotidyl transferase (Amersham Pharmacia Biotech) at 37 °C for 15 min. The reaction was stopped by
incubation at 70 °C for 10 min. Five µl of the reaction mixture was subjected to PCR for 35 cycles using a tailed oligo(dG) primer (5'-CATATGTCGACGCGT(GGI)5G-3') and primer CP2 under the
following conditions: denaturation at 94 °C for 0.5 min, annealing
at 58 °C for 0.5 min, and extension at 72 °C for 1 min. To verify
the specificity of the amplified fragments from the RACE reactions, the
bands detected on the agarose gel were excised and subjected to PCR
using primers CP1 and CP2 under the conditions of the RACE PCR,
resulting in the expected 300-bp fragments.
 |
RESULTS |
NPY and PYY Induced Reorganization of Actin Stress Fibers--
To
investigate if cellular adhesion and growth in the intestine could be
modulated by activation of members of the Y receptor family, we tested
the effects of PYY and NPY on actin filament reorganization in the
hBRIE 380i cells. Nonconfluent hBRIE 380i cells were treated with PYY
or NPY for 30 min. Under these nonsynchronous conditions, both PYY and
NPY caused a small increase in cell proliferation as determined by
bromodeoxyuridine uptake (data not shown, but also reported by others
(6)) and had a pronounced effect on actin rearrangement of stress
filaments (Fig. 1). The PYY response seemed distinct from that of NPY. PYY elicited an immediate increase in
stress fiber assembly (Fig. 1, A and B), whereas
NPY induced the formation of membrane ruffling followed by stress fiber
formation (Fig. 1, C and D). The termination
points of stress fibers at the plasmalemma are most likely where focal
adhesions form and proteins such as the integrins are clustered to form
a link between the actin cytoskeleton and the ECM. We verified that at
least one member of the integrin family was expressed in the hBRIE 380i cells, the 1-integrin. The presence of
1-integrin was first determined by RT-PCR, resulting in
the identification of a fragment corresponding to nucleotides 41-653
of the published rat cDNA sequence (23) (data not shown). Then the
expression of the entire mRNA for 1-integrin was
confirmed by Northern analysis (see below and Fig.
2A).

View larger version (161K):
[in this window]
[in a new window]
|
Fig. 1.
Demonstration of the alignment of actin
stress filaments in response to PYY and NPY treatment of the hBRIE 380i
cells. Subconfluent hBRIE 380i cells were treated with 100 nM PYY (A and B) or NPY (C
and D) in limiting medium (0.1% BCS) or limiting medium
alone (E) for 30 min, stained with tetramethyl rhodamine
isothiocyanate/phalloidin, and visualized by fluorescent microscopy.
With PYY, grouped cells became separated, compared with control
(E) and formed stress fibers and focal adhesions
(A and B) (arrows). With NPY, grouped
cells also separated (C and D) and formed
membrane ruffles (arrows).
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Northern analysis demonstrating the induction
of clusterin and CD63 mRNA levels in response to PYY, and the
presence of 1-integrin in the
hBRIE 380i cells. Cells were incubated with 100 nM PYY
or NPY for 6 h in limiting medium (0.1% BCS in IMDM) or with
limiting medium alone. Total RNA was isolated, separated, and
hybridized to labeled cDNA probes for 1-integrin
(A), clusterin (B), and CD63 (C) as
described under "Experimental Procedures." Each lane contains 30 µg of total RNA. Lanes P and N
represent cells incubated with 100 nM PYY and NPY,
respectively, and lane C represents cells treated
with limiting medium alone. Induction of CD63 (C) and
clusterin (B) mRNA levels was observed in response to
PYY (lanes P) when normalized to -actin or
glyceraldehyde-3-phosphate dehydrogenase, respectively (displayed in
the lower panels). A slight induction of
clusterin but not of CD63 transcripts was observed in response to NPY
(B and C, lanes N). No
induction of 1-integrin mRNA levels (A)
was observed in the presence of either PYY or NPY when normalized to
-actin (lower panel). The positions for 1.0-, 2.0-, and 3.0-kb RNA markers are indicated.
|
|
PYY Regulation of Genes Coding for Proteins Involved in Cell
Growth, Adhesion, and the Cytoskeleton--
We previously established
that I-FABP mRNA, used as a marker for differentiation in the hBRIE
380i cells, was induced in response to 100 nM PYY after
6 h of incubation (9). A slight increase in I-FABP mRNA levels
was also observed when the cells were treated with 100 nM
NPY for 6 h.2 These data
demonstrated that PYY/NPY induced the expression of a
differentiation-dependent protein marker, I-FABP, and
indicated that the peptides might regulate other processes related to
cellular growth/differentiation in the intestinal epithelium. To
further explore genes that could be involved in cellular
differentiation and would rapidly respond to the activation of Y
receptors, subtractive hybridization was performed using a recently
developed PCR-select cDNA subtraction methodology that enables the
detection of low abundant transcripts. Two subtractive libraries from
the hBRIE 380i cells were constructed corresponding to PYY-induced and
-repressed mRNAs. Two subsequent screenings of each library
resulted in over 200 clones that could be PYY-regulated genes (not yet
verified). Selected cDNA clones were sequenced and compared with
nucleotide sequences in the GenBankTM data base. Several of
these clones shared identities with genes whose products are involved
in cell growth, motility, and the cytoskeleton. One of these was a
965-bp fragment containing a 296-bp region with 94% identity to human
and mouse EST clones with regions of homology to the
Drosophila actin-binding protein 8, anillin, suggested to
play a role in the stabilization of contractile domains of the actin
cytoskeleton during cytokinesis (22). The regions of similarity include
the third proposed nuclear translocation domain of anillin. Another
cDNA clone, a 1.5-kb fragment, had 87% identity with TMP from
mouse brain tumors, which is also highly expressed in embryonic stem
cells (21). The transcripts corresponding to the TMP and anillin-like
genes were of low abundance. Only the message for the anillin-like
protein could be detected in the hBRIE cells by Northern analysis and
was determined to be about 4 kb (data not shown). This message size is
similar to that for anillin in Drosophila reported to be 4.0 and 4.3 kb (22). Due to the low levels of expression of both the
anillin-like protein and TMP, it has not yet been verified that PYY
induced these messages in the hBRIE 380i cells.
Another cDNA clone contained a 123-bp cDNA fragment with
identical sequence to a region of the cDNA for rat clusterin, a
protein found to inhibit cell aggregation (30-32). Full-length
transcripts for clusterin (2 kb) have been reported for several tissues
in different species (30). Northern analysis revealed a 1.8-2.0-kb mRNA in the hBRIE 380i cells (Fig. 2B). This transcript
was abundantly expressed in the hBRIE cells and appeared to be slightly
induced in response to both PYY and NPY (Fig. 2B). After
normalizing the signals to glyceraldehyde-3-phosphate dehydrogenase
used as a control (lower panel), the response to
PYY (lane P) was greater than for NPY
(lane N) when compared with cells incubated with medium alone (lane C). The apparent small changes
in mRNA levels are probably due to localization of transcripts to
specific cell populations of the hBRIE 380i cells. We have previously
demonstrated that these cells form both a differentiated cluster cell
population and less mature monolayer cells and that the
differentiationdependent marker I-FABP was only expressed and
regulated in the more differentiated cluster cells (9).
Another cDNA fragment of 601 bp had sequence identity to the rat
transmembrane-4 glycoprotein termed CD63, a protein previously shown to
associate with 1-integrin in various cell lines and presumed to modulate cellular adhesion properties (14, 19). To verify
that the CD63 transcripts were regulated by PYY (as indicated by the
partial cDNA sequence obtained from the subtractive library), the
hBRIE 380i cells were incubated with PYY for 6 h, under similar
culture conditions used for construction of the subtractive library,
and subjected to Northern analysis. Typical results are shown in Fig.
2C, demonstrating a strong signal for CD63 mRNA in the
hBRIE 380i cells at approximately 1.1-1.2 kb. Previous studies
indicated similar size transcripts for CD63 in rat mast cells, rabbit
aorta, and murine kidney, lung, intestine, and macrophages (18, 19,
33). Lanes P and C represent cells incubated with PYY and control media, respectively. Only PYY appeared to induce CD63 mRNA levels when normalized to the signal for
-actin (lane P and lower
panel). No increase in CD63 message levels was observed with
the addition of NPY to the culture medium (lane N). The difference in response to PYY and NPY might be
explained by the expression of multiple subtypes of the Y receptor
family and/or coupling of these receptors to different intracellular signaling systems. Although the increase in the message level was
higher for CD63 than for clusterin in response to PYY, both observations may be an underestimation of the responsiveness if these
transcripts, like I-FABP mRNA, were localized to a specific cell
population of the hBRIE 380i cells. Small changes in CD63 mRNA
levels as determined in the heterogeneous cell population could
represent large differences in a specific cell population, as
previously demonstrated for I-FABP (9). It remains to be determined
whether CD63 expression also is regulated in this manner.
In these initial studies, we chose to focus on the CD63 gene because of
the proposed relationship with cell adhesion/migration through
interactions with integrins. The CD63 cDNA fragment obtained from
our subtractive hybridization corresponding to nucleotides 36-646 of
the CD63 cDNA from rat basophilic leukemia cells (RBL-2H3) (18) is
diagrammed in Fig. 3A. To
verify the size of the CD63 transcript in the hBRIE 380i cells, RT-PCR
was performed. Amplification of the 3' cDNA end resulted in an
approximately 800-bp fragment (Fig. 3B, lane
1), while amplification of the 5' cDNA end resulted in
two fragments of approximately 500 and 600 bp (Fig. 3B,
lane 2) that might represent alternatively
spliced messages. All three fragments were confirmed to be CD63
cDNAs by amplifying a 308-bp region (Fig. 3B,
lanes 3-5) using two gene-specific primers (Fig. 3A, CP1 and CP2). The results suggest the presence of
full-length CD63 transcripts of about 1.0 and 1.1 kb in the hBRIE 380i
cells, in agreement with results from the Northern analysis (Fig.
2C). The isolated cDNA corresponded to the previously
reported full-length CD63 message containing the 714-bp coding region
(18).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 3.
Diagrams of CD63 cDNA and RT-PCR analysis
of CD63 mRNA in hBRIE 380i cells. A schematic representation
of rat CD63 cDNA (18) is illustrated in A. The
box indicates the open reading frame, with the regions for
transmembrane domains shaded. The 611-bp fragment represents
a partial cDNA obtained through subtractive hybridization. The 800- and 500-bp fragments are the results of 3'- and 5'-RACE. Typical
results from RT-PCR and RACE analysis of CD63 transcripts in the hBRIE
380i cells are represented by the agarose gel. B, fragments
of approximately 800 and 500 bp (and 600 bp) were obtained from the 3'-
and 5'-RACE reactions, respectively (lanes 1 and
2). Amplification of the 800-bp cDNA (lane 1) using primers CP1 and CP2 resulted in an expected 308-bp
fragment (lane 3). Further PCR analysis of the
500- and 600-bp fragments (in lane 2) using the
CP1 and CP2 primers also resulted in the expected 308-bp cDNA
(lanes 4 and 5). The molecular weight
markers (100-bp ladder) are shown (lane M).
|
|
To determine whether the PYY-inducible CD63 transcript identified in
the hBRIE 380i cells was also present in the native intestinal epithelium, Northern analysis was performed on total RNA isolated from
an epithelial cell fraction of rat small intestine. The presence of
CD63 mRNA in intestinal epithelial cells is shown in Fig.
4. The message was of identical size to
that observed in the hBRIE 380i cells and is in agreement with the
RT-PCR data (see above and Fig. 2C). It was also confirmed
that the mRNA species identified by Northern blot analysis was
identical to the cloned rat CD63 cDNA by using a labeled cDNA
probe specific for codons 104-202 (18), corresponding to the
extracellular domain of the protein. Using this probe, a strong
mRNA signal of identical size was observed in both the hBRIE 380i
cells and the intestinal epithelium (data not shown). The CD63 mRNA
appeared to be highly abundant in both native intestinal epithelial
cells and the hBRIE 380i cells (compared with -actin).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Northern analysis demonstrating the presence
of CD63 mRNA in rat intestinal epithelial cells. An intestinal
epithelial cell fraction was prepared, and total RNA was isolated. The
autoradiogram represents 30 µg of total RNA hybridized to a
-32P-labeled CD63 cDNA probe as described under
"Experimental Procedures." A strong signal at 1.1-1.2 kb was
detected for the message and was identical to that observed in the
hBRIE 380i cells. The positions for 1.0- and 2.0-kb RNA markers are
indicated.
|
|
To further investigate a potential link between PYY receptor
activation, rearrangements of the actin cytoskeleton, and induction of
CD63, we tested for the regulation of 1-integrin
expression whose presence in the hBRIE 380i cells we had already
established by RT-PCR (not shown). The hBRIE 380i cells were treated
with 100 nM of either NPY or PYY for 6 h; total RNA
was isolated; and mRNA levels were determined using Northern
analysis. Typical results are shown in Fig. 2A,
demonstrating that the 1-integrin message was not
regulated by either PYY or NPY (lanes P and
N, respectively) when compared with the control
(lane C, medium alone) and normalized to
-actin shown in the lower panel. The
1-integrin mRNA was determined to be about 3 kb
(Fig. 2A) as expected from previous cloning data reporting
the 1-integrin coding region to be 2.4 kb in rat
oligodendrocytes (23).
CD63 Expression in Cells Forming Differentiated Clusters in the
hBRIE 380i Cells--
CD63 was found to be most abundantly expressed
in the clusters of hBRIE 380i cells, which are composed primarily of
differentiated cells. These differentiated clusters of cells have been
previously shown to be localized in areas where the cells have become
morphologically columnar, polarized, with apical microvilli, and to
express proteins such as I-FABP (Fig. 5,
A and B, and Fig. 7B,
arrow). Cells dispersed from these clusters revealed CD63
immunoreactivity in vesicular structures that appeared similar to
lysosomal compartments (Fig. 5C, arrow). This
pattern of cellular distribution was similar to that reported in a
number of cell lines (18). No immunoreactivity was observed when the
antisera had been preabsorbed with recombinant CD63 at a concentration
greater than 25 ng/µl (Fig. 5D).

View larger version (131K):
[in this window]
[in a new window]
|
Fig. 5.
Immunocytochemical localization of CD63 to
the differentiated clusters of the hBRIE 380i cells. The hBRIE
cells were grown on a collagen substratum. On day 7 past confluency,
the cells were fixed and stained for CD63, using GpAb4120ex antiserum,
as described under "Experimental Procedures." A, an
incandescent micrograph of a cluster of cells surrounded by a
monolayer. The identical field of cells using immunofluorescence
microscopy, visualized by fluorescein isothiocyanate, revealed CD63 to
be primarily localized to the cell clusters (B).
Bar, 65 µm (A and B). Cells grown as
above but dispersed, cytospun, and fixed onto microscope slides prior
to immunolocalization revealed CD63 immunoreactivity in a punctate
vesicular pattern ranging from the perinuclear regions to the cell
surface (C, arrow). D, hBRIE 380i
cells immunostained using GpAb4120ex, which had been preabsorbed with
recombinant CD63. Bar, 30 µm (C and
D).
|
|
To determine whether CD63 could be involved in the formation of
differentiated clusters in the hBRIE 380i cells, the cells were
transfected with CD63 antisense cDNA. Cells expressing decreased levels of CD63 mRNA were identified using RT-PCR. The data
presented in this study are from one clone of these cells (hBRIE
380iCD63-as cells) whose CD63 mRNA levels were
nondetectable (Fig. 6, lane 3). For each cell clone, a 594-bp CD63 cDNA was
amplified, and the results were normalized to rat -actin cDNA
levels (Fig. 6, lower panel). The controls (Fig.
6, lanes 1 and 2), expressing normal
levels of CD63 mRNA, were hBRIE 380i cells (lane
1) and cells transfected with CD63 sense cDNA (hBRIE
380iCD63+s cells) (lane 2).

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 6.
Agarose gel of RT-PCR analysis demonstrating
decreased levels of CD63 mRNA in hBRIE 380i cells transfected with
a CD63 antisense sequence. The hBRIE 380i cells transfected with
CD63 antisense and sense cDNA were selected, and relative abundance
of CD63 mRNA was determined by RT-PCR as described under
"Experimental Procedures." The amplified 594-bp rat CD63 cDNA
was normalized to the 811-bp rat -actin cDNA (lower panel) in each cell clone and compared with the
untransfected hBRIE 380i cells (lane 1) and cells
transfected with the sense CD63 cDNA (hBRIE 380iCD63+s)
(lane 2), both expressing normal levels of CD63
mRNA. Lane 3, one of the antisense cell
clones expressing highly decreased levels of CD63 mRNA when
compared with the controls (lane 1 and
2). This cell clone, the hBRIE 380iCD63-as
(lane 3), was used in the present study.
|
|
Unlike untransfected hBRIE 380i cells (Fig.
7, A and B, and
Fig. 8, A and B)
and cells transfected with the CD63 sense cDNA (Fig. 8,
C and D), the hBRIE 380iCD63-as cells
failed to produce differentiated clusters of cells (Fig. 7,
C and D). In untransfected cells, cluster
formation was dependent on the presence of a collagen substratum. In
the absence of this matrix, cells formed ridges (Fig. 7A,
arrow) rather than clusters (Fig. 7B,
arrow) and lacked the phenotypic characteristics of differentiated cells, as described previously (8, 9). The hBRIE
380iCD63-as cells displayed a strong reduction of cell
cluster formation as well as cell ridges (Fig. 7, C and
D). This occurred independently of the presence of the
collagen matrix. Cells transfected with CD63 antisense cDNA, which
had moderately repressed CD63 mRNA levels when compared with normal
cells or hBRIE 380iCD63-as cells, demonstrated more
collagen-dependent cluster formation than the hBRIE
380iCD63-as cells but less than untransfected cells (data
not shown). These data suggest that CD63 is necessary for the cells to
maintain interactions with the ECM, such as cell adhesion, that are
required for differentiation.

View larger version (132K):
[in this window]
[in a new window]
|
Fig. 7.
Light micrographs of hBRIE 380i cells
demonstrating the absence of clusters in cells expressing decreased
levels of CD63 mRNA. A and B, the hBRIE
380i cells were grown to 7 days past confluency on either tissue
culture plastic (A) or type I collagen (B). As
described previously (8, 9), cells on the matrix form differentiated
cell clusters (B, arrow), while those without
substrate form ridges of cells (A, arrow) lacking
a differentiated phenotype. Cells transfected with CD63 antisense
cDNA (the hBRIE 380iCD63-as cells) failed to form
ridges on matrix-free tissue culture plates (C) and
displayed a loss of differentiated cell cluster formation when grown on
the collagen matrix (D). Bar, 100 µm
(A-D).
|
|

View larger version (122K):
[in this window]
[in a new window]
|
Fig. 8.
Lightmicrographs of normal hBRIE 380i cells
and cells transfected with CD63 sense cDNA demonstrating no change
in cluster formation. Cells were grown under identical conditions
as those used in the antisense studies in Fig. 7. No differences were
detected between normal cells (hBRIE 380i cells) (A and
B) or cells transfected with the CD63 sense cDNA (hBRIE
380iCD63+s cells) (C and D), neither
when the cells were grown on tissue culture plastic (A and
C) nor on collagen (B and D). The
hBRIE 380iCD63+s cells developed cell clusters
(D, arrow) in similar appearance and numbers as
hBRIE 380i cells (B, arrow) when grown on a
collagen matrix and formed ridges when grown on plastic (A
and C, arrows). Bar, 75 µm
(A-D).
|
|
Two Y Receptors Are Expressed in the hBRIE 380i Cells and the
Intestine--
Numerous Y receptor subtypes have previously been
described in both the intestinal epithelium and enteric nervous system
and reported to activate biological activities such as motility and secretion in the gut. Our data demonstrate that both NPY and PYY induce
actin rearrangement in the hBRIE 380i cells and that the response was
different for each peptide. In addition, the induction of mRNA
levels for CD63 and clusterin by PYY was more pronounced than by NPY.
Together these observations indicate the activation of multiple Y
receptors and/or intracellular signaling systems in the hBRIE 380i
cells. The expression of the Y1 and Y2 receptor subtypes in the
intestine has previously been determined (34, 35); however, the Y2
receptor had not yet been identified in intestinal epithelial cells.
Therefore, we tested for the presence of a number of Y receptors
previously identified in various tissues and species. In the present
study, we established the presence of both the Y1 and Y2 receptors in
the hBRIE 380i cells and intact intestinal epithelial cells by
RT-PCR.
The Y1 receptor was cloned using primers (Fig.
9A) synthesized based on the
rat forebrain Y1 cDNA sequence (25). The Y1 receptor is
alternatively spliced in murine tissues, resulting in two transcripts
coding for an and subtype (36), with the subtype lacking
the C terminus and part of the seventh transmembrane domain. The subtype was demonstrated to be the predominant form of the receptor in
adult murine tissue (36). Using primers Y1P1 and Y1P2, designed to be
specific for the Y1 receptor, we obtained an expected 745-bp
fragment from the hBRIE 380i cells, confirmed by sequencing to be
identical to the Y1 receptor cDNA (Fig. 9A) (25). The
RT-PCR was repeated on RNA isolated from both the hBRIE 380i cells and
native intestinal epithelial cells to clone the entire coding region of
the Y1 receptor cDNA using primers Y1P3 and Y1P4. We obtained a
1149-bp fragment from each of the RT-PCR reactions with the same
sequence as the published rat Y1 sequence (Fig. 9A). These
results demonstrated that Y1 receptor transcripts were present in the
hBRIE 380i and intestinal epithelial cells, indicating that the Y1
receptor is expressed in the intestinal epithelium.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 9.
Cloning of the Y1 receptor from the hBRIE 380i cells and intestinal epithelial
cells by RT-PCR. The diagrams in A illustrate the
structure of the Y1 cDNA (25) and the cDNA fragments cloned
from the hBRIE 380i cells and the intestine using receptor
subtype-specific primers. The box represents the coding
region, with the sequences for transmembrane domains shaded.
A 745-bp cDNA fragment was obtained from the hBRIE 380i cells using
primers Y1P1 and Y1P2. The 1149-bp cDNA fragment corresponds to the
full coding region of the Y1 receptor isolated from hBRIE 380i cells
and native intestinal epithelial cells using primers Y1P3 and Y1P4. The
agarose gel (B) demonstrates the presence of Y1 receptor
transcripts in hBRIE 380i cells, BRIE 291 cells, PC12 cells, rat
intestinal epithelial cells, and cerebral cortex using primers Y1P4 and
Y1P5, amplifying a 407-bp cDNA fragment. An 811-bp -actin
cDNA fragment was amplified and used as an internal control in each
reaction (lower panel).
|
|
To test if the hBRIE 380i cells also expressed the Y2 receptor, RT-PCR
analysis was performed using degenerate primers, Y2P1 and Y2P2,
designed based on the rat Y2 receptor amino acid sequence (37). A
659-bp cDNA fragment spanning transmembrane regions 3-7 was
obtained as expected and confirmed by sequencing to be the correct Y2
receptor cDNA fragment (Fig.
10A). To verify the presence
of Y2 receptor transcripts in the hBRIE 380i cells and intestinal
epithelial cells, we repeated the RT-PCR assay using a pair of
degenerate primers, Y2P3 and Y2P4, synthesized based on the published
rat Y2 amino acid sequence (37) amplifying the entire coding region of
the receptor (Fig. 10A). We obtained a 1146-bp fragment
that, after sequencing, was confirmed to be Y2 cDNA based on its
homology with the published human neuroblastoma (27) and mouse brain Y2
cDNA sequence (28). This sequence was also identical to that of the
Y2 receptor cDNA from rat hypothalamus that was reported during the
course of our study (38), and the deduced amino acid sequence was
identical to the previously published rat Y2 amino acid sequence (37).
These results clearly demonstrate the presence of Y2 receptor
transcripts in the epithelial cell population of intestinal cells in
addition to the previously reported expression only in the enteric
nervous system (34, 39).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 10.
Cloning of the Y2 receptor from the hBRIE
380i cells and intestinal epithelial cells by RT-PCR. The diagrams
in A illustrate the rat Y2 receptor cDNA derived from
the amino acid sequence and the cDNA fragments cloned from the
hBRIE 380i cells and the intestine using degenerate primers. The
regions encoding the transmembrane domains are shaded. A
659-bp fragment was isolated from the hBRIE 380i cells using primers
Y2P1 and Y2P2. The 1146-bp cDNA represents the entire coding region
and was cloned from both hBRIE 380i cells and native intestinal
epithelial cells using primers Y2P3 and Y2P4. Primers Y2P3 and Y2P5
were used to amplify a 947-bp fragment for identification of the
receptor in various tissues and cell lines (B). The agarose
gel (B) demonstrates the presence of Y2 receptor transcripts
in hBRIE 380i cells, PC12 cells, rat intestinal epithelial cells, and
cerebral cortex. No Y2 cDNA could be isolated from the BRIE 291 cells. An 811-bp -actin cDNA fragment was amplified and used as
an internal control in each reaction (lower panel).
|
|
To further verify the specificity of the RT-PCR for both the Y1 and Y2
receptors, RT-PCR was performed on tissues and cells previously
established to be positive and negative for the receptors. Primers Y1P5
and Y1P4 (Fig. 9A) were used to amplify a 407-bp fragment
specific for the Y1 cDNA in these cells and tissue preparations (Fig. 9B). Similarly, a 947-bp fragment of the Y2 cDNA
was amplified in the same cells and tissue preparations using primers
Y2P3 and Y2P5 (Fig. 10, A and B). As expected,
rat cerebral cortex, a tissue previously reported to have a high
density of both Y1 and Y2 receptors (40), expressed both the Y1 and Y2
subtypes (Figs. 9B and 10B). The pheochromocytoma
cell line, PC12, also expressed both the Y1 and Y2 receptors (Figs.
9B and 10B) as previously determined (41). The
rat intestinal epithelial cell line, BRIE 291, was positive only for
the Y1 receptor (Figs. 9B and 10B), and the hBRIE 380i cells like the intestinal epithelium expressed both the Y1 and the
Y2 subtypes (Figs. 9B and 10B), in agreement with
our previous cloning data (see above). The hBRIE 380i cells were
created by somatic cell fusion of the rat small intestinal epithelial
cell line, BRIE 291 cells, with terminally differentiated intestinal epithelial cells (7). Therefore, these results confirm that both the Y1
and Y2 receptor expression in the hBRIE 380i cells were of epithelial origin.
 |
DISCUSSION |
The high rate of proliferation of the intestinal epithelium and
its balance with cell migration, adhesion, and terminal differentiation in a temporal and spacially specific manner is a process that must be
closely regulated to preserve functional cell steady state. Critical
questions lie in the potential contribution of peptide growth factors
to these processes. Several peptide growth factors have been described
for the intestine such as the epidermal growth factors, transforming
growth factors and , insulin-like growth factors, and the
fibroblast growth factors (for a comprehensive review see Ref. 42).
However, the role of neuro-gut regulatory peptides such as NPY and PYY
on differentiation of the gut remains relatively unexplored. Because
these peptides can both be secreted and act locally, they are likely
candidates as regulators of intestinal protein expression. Other
diverse elements may be equally important in the regulation of
differentiation. Elements that probably modulate the effects of peptide
growth factors are the constituents of the ECM that are produced by
both the epithelial cells and other cellular populations within the
lamina propria, such as pericryptal fibroblasts (43, 44).
PYY and NPY are members of a 36-amino acid regulatory peptide family
that includes pancreatic polypeptide. PYY shares a common structural
motif with NPY as well as more than 70% sequence identity (45). While
PYY-secreting cells occur mainly in the distal small intestine and the
large intestine; NPY is abundantly expressed in all noradrenergic
nerves innervating blood vessels and heart, as well as brain (46),
adrenal medulla, intrinsic cardiac neurons (47), and the myenteric
plexus of the gut (48-50). In addition to being localized to
sympathetic neurons, NPY is also colocalized with catecholamines,
acetylcholine, and enkephalins. PYY and NPY share several biological
functions including inhibition of GI motility and chloride ion secretion.
In the present study, we demonstrated that NPY and PYY induced
rearrangement of actin filaments in the hBRIE 380i cells. The PYY
response seemed to be distinct from that of NPY. PYY elicited an
immediate increase in stress fiber assembly, whereas NPY induced the
formation of membrane ruffling followed by stress fiber formation. The
termination points of stress fibers at the plasmalemma are thought to
be where focal adhesions form and where proteins such as integrins are
clustered and form a link between the actin cytoskeleton and the ECM.
This process has been suggested to be dependent on Rho p21, while
membrane ruffling, which was observed in the presence of NPY, has been
reported to be a process requiring Rac p21 in Swiss 3T3 fibroblasts
(51, 52). In epithelial cells small Rho-like GTPases have also been
shown to be required for both cell migration and cell-to-cell adhesion.
Recent data suggest that the activity of Rho-like GTPases is also
required to maintain the cytoskeletal architecture of polarized
Madin-Darby canine kidney cells (53) and that Rac is necessary for cell
motility (54). Activation of GTP-binding proteins and focal adhesion kinase may be central in the signaling cascade initiated by integrins (55-57). These pathways may overlap with those initiated by regulatory peptides such as PYY and NPY to function synergistically.
Data from subtractive hybridization demonstrated a number of genes to
be either induced or repressed by NPY and PYY. Several of the sequenced
and identified genes were similar to those coding for proteins
previously reported to participate in cell growth, adhesion, and
migration in other tissues and cell lines. Examples of those gene
products were a TMP (21), an anillin-like protein (22), clusterin
(30-32), and CD63 (14, 19). We chose to investigate the association
between Y receptor activation and CD63 mRNA induction because of
data suggesting that integrin-CD63 interactions play a role in cell
adhesion (14), a process regulating reorganization of actin filaments.
CD63 belongs to a family of newly identified TM4SF membrane proteins
(58) that are characterized by four transmembrane domains. Members of
this family such as CD9, CD37, CD53, CD81, and CD82 (59, 60) have been
found to be expressed in leukocytes and a variety of other mammalian
tissues. CD63 appears on the surface of most cultured cell lines at a
moderate level (18). It is also found incorporated into membranes of
different types of intracellular granules, including lysosomes (18,
61), endothelial Weibel-Palade bodies (62), platelet-dense granules
(63), and the major histocompatibility complex class II compartment
(64).
CD63 has been reported to suppress random tumor cell motility and
enhance migration toward the 1-integrin substrates:
fibronectin, laminin, and collagen. Specific associations between
membrane proteins in the TM4SF and certain 1 integrins
including 3 1, 6 1, and 4 1
have been previously described (65-67). A role for these TM4SF
proteins in signaling is suggested by the demonstration of their
modulation of intracellular calcium, tyrosine phosphorylation, and cell
proliferation (57, 68). However, the mechanism whereby TM4SF proteins
are involved in this signaling is not understood. It has been reported
that phosphatidylinositol 4-kinase is associated with
3 1 integrin and TM4SF proteins (15).
Therefore, the integrins-TM4SF complexes could be a point of merger
with integrin and TM4SF protein signaling (15). Cell attachment
mediated by transmembrane receptors in the integrin family has been
shown to trigger signal transduction cascades that regulate cell
proliferation, apoptosis, motility, and morphology.
We demonstrated that CD63 antisense cell clones (hBRIE
380iCD63-as cells) lost the expression of CD63, determined
by immunocytochemistry, and did not display the differentiated cluster
cells typical of the hBRIE380i cells. The hBRIE 380i cells grown on a
collagen matrix form clusters of cells that appear 3-4 days after
confluency comprising primarily nondividing differentiated cell
populations (8, 9). Unlike the hBRIE 380i cells the hBRIE
380iCD63-as cells had a similar appearance of newly
confluent hBRIE 380i cells grown on tissue culture plastic without the
collagen substratum. Additionally, the hBRIE 380iCD63-as
cells lost the expression of the differentiation marker I-FABP (data
not shown). The loss of the characteristic properties of differentiated
hBRIE 380i cells with decreased levels of CD63 implicates an important
role for this tetraspanin in intestinal cell differentiation possibly
through its effects on cellular adhesion (cell to cell or cell to
matrix). These studies utilizing the hBRIE 380iCD63-as
suggest that neuro-gut regulatory peptides can regulate cytoskeletal protein expression by facilitating protein signals from the basement membrane to induce cell differentiation.
CD63 immunoreactivity, determined utilizing GpAb4120ex made against the
extracellular domain of recombinant rat CD63, was localized in
vesicular structures distributed throughout the cell cytoplasm as well
as in a punctate pattern of distribution on the cell surface. Our
observations are consistent with reports of CD63 as a lysosomal
membrane glycoprotein expressed on the surface of other cells, such as
T-lymphocytes (69), neutrophils (70), and basophils (71). CD63
immunoreactivity was also localized primarily to the clusters of hBRIE
380i cells. This morphologically distinct region has been determined to
be the site of differentiation-dependent protein expression
such as I-FABP (9). CD63 localization to these clusters indicates that
determination of mRNA levels by Northern analysis or ribonuclease
protection assay could be underestimating the changes in expression in
response to stimuli. For example, I-FABP transcripts were demonstrated
to change 2-fold in response to PYY as determined by ribonuclease
protection assay (9). By quantitative in situ hybridization,
it was found that I-FABP transcripts were confined only to the
differentiated cluster population of cells. In these cell populations,
there was over a 5-fold induction of the message level (9). Although
further studies need to be performed to determine the responsiveness of
the heterogeneous hBRIE 380i cells to PYY and NPY, it is clear that
these cells as a total population display different sensitivities to
these peptides. This raises the possibility that the actions of PYY and
NPY on cytoskeletal elements in the epithelial cells may occur through
more than one pathway and by more than one Y receptor subtype.
A number of Y receptor subtypes have been previously identified in
various species and tissues by characterization of ligand binding and
receptor activation using binding and functional assays (34, 72-75).
At least six different subtypes have been determined based on the order
of agonist potency and antagonist specificity in various tissues, with
each cell type displaying a specific receptor profile (40, 75-79). All
characterized Y receptors appear to be G-protein-coupled (76). The
cDNAs for Y1, Y2, Y4, Y5, and Y6 have been cloned from a number of
species and tissues (26, 80-83). However, the presence of transcripts
for each specific Y receptor subtype in native intestinal epithelial
cells has not been clearly determined. Recently, partial cDNAs for
the Y2, Y4, and Y5 receptors were isolated from epithelial cells in the
rat small and large intestine by RT-PCR, while the Y1 cDNA was
found predominantly in nonepithelial colonic tissue (84).
To determine what Y receptor subtype could be involved in the response
to PYY and NPY in the hBRIE 380i cells, we designed degenerate PCR
primers based on previously published sequence data for the Y1-Y5
receptors from various species (25, 26, 79-82). In this study, we
establish the presence of two of these receptors, the Y1 and Y2
subtypes, in both the hBRIE 380i cells and the intact intestinal
epithelium. It has previously been reported that the Y1 subtype is
present in the intestinal mucosa, in epithelial cells as well as
enteric neurons (34, 35, 73, 85). The presence of a Y2 receptor in the
intestine has also been demonstrated, although this receptor subtype
has been suggested to be localized to the neuronal cells rather than
the epithelial cells (34, 39). With the exception of the identification
and sequencing of a small nucleotide fragment from rat intestinal
mucosa (84), the present study is the first to identify the complete
coding region for the Y2 receptors outside of nervous tissues.
It has been reported that the Y3, Y4, and Y5 subtypes are also
present in the small and large intestine using specific agonists and
antagonists (77). However, it has not been conclusively demonstrated
which Y receptor subtype(s) is responsible for specific biological
effects such as motility, antisecretory activities, or modulation of
cell growth and differentiation in the intestine. Reasons for this
include (i) difficulties involved in the isolation of a pure population
of intestinal cells from a mixture of cells including nerve plexa,
intraepithelial lymphocytes, enteroendocrine, and smooth muscle cells;
(ii) low abundance of receptors; (iii) overlap in specificity of
ligands; and (iv) small differences in binding affinities of ligands
used in functional assays that often cross-react with several of the Y
receptors. Both NPY and PYY bind with similar affinities to all
subtypes except to the Y3 receptor, which has been demonstrated to bind
NPY but not PYY (76, 86). A peripheral PYY-preferring receptor subtype
has been proposed but not yet identified (87, 88). Consequently, neither the differences in actin reorganization that we observed with
the two peptides nor the higher level of induction of CD63 and
clusterin transcripts in response to PYY can be fully explained by the
presence of the Y1 and Y2 receptors in the hBRIE cells. While each Y
receptor may account for specific biological responses, multiple
receptors may have overlapping actions on cell maturation as indicated
by the induction of proteins associated with the cytoskeleton and cell
differentiation (i.e. CD63, clusterin, and I-FABP) and the
induction of actin rearrangement by NPY and PYY. Both the Y1 and Y2
subtypes can activate at least two separate intracellular messenger
cascades (inhibition of cAMP accumulation and stimulation of inositol
1,4,5-trisphosphate followed by elevated intracellular
Ca2+) in a tissue- and cell type-specific manner (77, 78).
Either the Y1 or Y2 receptor could act through one of these pathways in
the intestine and also act synergistically with other receptors through
intracellular cross-talk to potentiate effects on cell maturation and
CD63 expression. Therefore, the observed differences in actin
rearrangement and induction of CD63 and clusterin transcripts, in
response to PYY and NPY, could be due to the activation of a
combination of the Y1 , the Y2, or another yet-to-be-identified Y
receptor subtype in the hBRIE 380i cells.
The present study provides a mechanism whereby intestinal
neuroregulatory peptides could regulate mucosal cell migration and differentiation through the modulation of tetraspanins. This mechanism helps build a model to explain how extracellular cues could establish the temporal and spacial expression of proteins in the intestine. The
regulation of CD63 expression might be a point of convergence where the
effects of ECM factors necessary for growth and differentiation are
modulated by neuro-gut peptides. It is possible that Y1/Y2 activation
induces TM4SF complex formation with 1-integrins such as
CD81-PI4K-CD63-integrin (15) through CD63, which in turn helps initiate
the process of actin polymerization necessary for cell adhesion and the
basolateral "sampling" of ECM components laid down by the
surrounding cells along the crypt to villus axis. The presence of
specific proteins in these areas, detected by receptors or through
basolateral endocytic processing (an event also associated with CD63
(89)), could give rise to protein expression in both a temporal and
positional fashion along the villus. This model may explain how mucosal
cell differentiation and growth could be closely linked to cell
migration and adhesion and regulated by neuro-gut regulatory peptides.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom all correspondence should be addressed: Dept. of
Nutritional Sciences, 119 Morgan Hall, University of California, Berkeley, CA 94720-3104. Tel.: 510-642-7226; Fax: 510-642-0535; E-mail:
gwa@nature.berkeley.edu.
2
G. Halldén, M. Hadi, H. T. Hong, and
G. W. Aponte, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
ECM, extracellular
matrix;
PYY, peptide YY;
NPY, neuropeptide Y;
I-FABP, intestinal fatty
acid binding protein;
TM4SF, transmembrane-4 superfamily protein;
IMDM, Iscove's modified Dulbecco's medium;
BCS, bovine calf serum;
RT, reverse transcription;
PCR, polymerase chain reaction;
kb, kilobase pair(s);
bp, base pair(s);
TM, transmembrane region;
RACE, rapid
amplification of cDNA ends.
 |
REFERENCES |
| 1.
|
Stoker, A. W.,
Streuli, C. H.,
Martins-Green, M.,
and Bissell, M. J.
(1990)
Curr. Opin. Cell Biol.
2,
864-874[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Iwase, K.,
Evers, B. M.,
Hellmich, M. R.,
Guo, Y. S.,
Higashide, S.,
Kim, H. J.,
and Townsend, C. M., Jr.
(1997)
Gastroenterology
113,
782-790[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Kiss, Z.,
Crilly, K. S.,
and Tomono, M.
(1997)
FEBS Lett.
415,
71-74[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Hollande, F.,
Imdahl, A.,
Mantamadiotis, T.,
Ciccotosto, G. D.,
Shulkes, A.,
and Baldwin, G. S.
(1997)
Gastroenterology
113,
1576-1588[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Todisco, A.,
Takeuchi, Y.,
Urumov, A.,
Yamada, J.,
Stepan, V. M.,
and Yamada, T.
(1997)
Am. J. Physiol.
273,
G891-G898[Abstract/Free Full Text]
|
| 6.
|
Voisin, T.,
Bens, M.,
Cluzeaud, F.,
Vandewalle, A.,
and Laburthe, M.
(1993)
J. Biol. Chem.
268,
20547-20554[Abstract/Free Full Text]
|
| 7.
|
Aponte, G. W.,
Keddie, A.,
Halldén, G.,
Hess, R.,
and Link, P.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
5282-5286[Abstract/Free Full Text]
|
| 8.
|
Halldén, G.,
Holehouse, E. L.,
Dong, X.,
and Aponte, G. W.
(1994)
Am. J. Physiol.
267,
G730-G743[Abstract/Free Full Text]
|
| 9.
|
Halldén, G.,
and Aponte, G. W.
(1997)
J. Biol. Chem.
272,
12591-12600[Abstract/Free Full Text]
|
| 10.
|
Holehouse, E.,
Liu, M. L.,
and Aponte, G. W.
(1998)
Biochim. Biophys. Acta
1390,
52-64[Medline]
[Order article via Infotrieve]
|
| 11.
|
Rubin, D. C.,
Ong, D. E.,
and Gordon, J. I.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
1278-1282[Abstract/Free Full Text]
|
| 12.
|
Rottman, J. N.,
and Gordon, J. I.
(1993)
J. Biol. Chem.
268,
11994-12002[Abstract/Free Full Text]
|
| 13.
|
Hermiston, M. L,
Simon, T. C.,
Crossman, M. W.,
and Gordon, J. I.
(1994)
in
Physiology of the Gastrointestinal Tract
(Johnson, L. R., ed)
, pp. 521-569, Raven Press, New York
|
| 14.
|
Radford, K. J.,
Thorne, R. F.,
and Hersey, P.
(1997)
J. Immunol.
158,
3353-3358[Abstract]
|
| 15.
|
Berditchevski, F.,
Tolias, K. F.,
Wong, K.,
Carpenter, C. L.,
and Hemler, M. E.
(1997)
J. Biol. Chem.
272,
2595-2598[Abstract/Free Full Text]
|
| 16.
|
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159[Medline]
[Order article via Infotrieve]
|
| 17.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1994)
Current Protocols in Molecular Biology
, John Wiley & Sons, Inc., New York
|
| 18.
|
Nishikata, H.,
Oliver, C.,
Mergenhagen, S. E.,
and Siraganian, R. P.
(1992)
J. Immunol.
149,
862-870[Abstract]
|
| 19.
|
Miyamoto, H.,
Homma, M.,
and Hotta, H.
(1994)
Biochim. Biophys. Acta
1217,
312-316[Medline]
[Order article via Infotrieve]
|
| 20.
|
French, L. E.,
Chonn, A.,
Ducrest, D.,
Baumann, B.,
Belin, D.,
Wohlwend, A.,
Kiss, J. Z.,
Sappino, A. P.,
Tschopp, J.,
and Schifferli, J. A.
(1993)
J. Cell Biol.
122,
1119-1130[Abstract/Free Full Text]
|
| 21.
|
Ben-Porath, I.,
and Benvenisty, N.
(1996)
Gene (Amst.)
183,
69-75[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Field, C. M.,
and Alberts, B. M.
(1995)
J. Cell Biol.
131,
165-178[Abstract/Free Full Text]
|
| 23.
|
Malek-Hedayat, S.,
and Rome, L. H.
(1995)
Gene (Amst.)
158,
287-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Keller, H. U.,
Zimmermann, A.,
and Cottier, H.
(1985)
Int. J. Cancer
36,
495-501[Medline]
[Order article via Infotrieve]
|
| 25.
|
Eva, C.,
Keinanen, K.,
Monyer, H.,
Seeburg, P.,
and Sprengel, R.
(1990)
FEBS Lett.
271,
81-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Herzog, H.,
Hort, Y. J.,
Ball, H. J.,
Hayes, G.,
Shine, J.,
and Selbie, L. A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5794-5798[Abstract/Free Full Text]
|
| 27.
|
Rose, P. M.,
Fernandes, P.,
Lynch, J. S.,
Frazier, S. T.,
Fisher, S. M.,
Kodukula, K.,
Kienzle, B.,
and Seethala, R.
(1995)
J. Biol. Chem.
270,
29038[Abstract/Free Full Text]
|
| 28.
|
Nakamura, M.,
Aoki, Y.,
and Hirano, D.
(1996)
Biochim. Biophys. Acta
1284,
134-137[Medline]
[Order article via Infotrieve]
|
| 29.
|
Nudel, U.,
Zakut, R.,
Shani, M.,
Neuman, S.,
Levy, Z.,
and Yaffe, D.
(1983)
Nucleic Acids Res.
11,
1759-1771[Abstract/Free Full Text]
|
| 30.
|
Choi-Miura, N. H.,
and Oda, T.
(1996)
Neurobiol. Aging
17,
717-722[Medline]
[Order article via Infotrieve]
|
| 31.
|
Wong, P.,
Pineault, J.,
Lakins, J.,
Taillefer, D.,
Leger, J.,
Wang, C.,
and Tenniswood, M.
(1993)
J. Biol. Chem.
268,
5021-5031[Abstract/Free Full Text]
|
| 32.
|
Blaschuk, O.,
Burdzy, K.,
and Fritz, I. B.
(1983)
J. Biol. Chem.
258,
7714-7720[Abstract/Free Full Text]
|
| 33.
|
Sohma, Y.,
Suzuki, T.,
Sasano, H.,
Nagura, H.,
Nose, M.,
and Yamamoto, T.
(1994)
Cell Struct. Funct.
19,
219-225[Medline]
[Order article via Infotrieve]
|
| 34.
|
Walsh, D. A.,
Wharton, J.,
Blake, D. R.,
and Polak, J. M.
(1993)
Br. J. Pharmacol.
108,
304-311[Medline]
[Order article via Infotrieve]
|
| 35.
|
Wharton, J.,
Gordon, L.,
Byrne, J.,
Herzog, H.,
Selbie, L. A.,
Moore, K.,
Sullivan, M. H.,
Elder, M. G.,
Moscoso, G.,
Taylor, K. M.,
Shine, J.,
and Polak, J. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
687-691[Abstract/Free Full Text]
|
| 36.
|
Nakamura, M.,
Sakanaka, C.,
Aoki, Y.,
Ogasawara, H.,
Tsuji, T.,
Kodama, H.,
Matsumoto, T.,
Shimizu, T.,
and Noma, M.
(1995)
J. Biol. Chem.
270,
30102-30110[Abstract/Free Full Text]
|
| 37.
|
Larhammar, D.
(1996)
Regul. Pept.
65,
165-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
St-Pierre, J. A.,
Dumont, Y.,
Nouel, D.,
Herzog, H.,
Hamel, E.,
and Quirion, R.
(1998)
Br. J. Pharmacol.
123,
183-194[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Servin, A. L.,
Rouyer-Fessard, C.,
Balasubramaniam, A.,
Saint Pierre, S.,
and Laburthe, M.
(1989)
Endocrinology
124,
692-700[Abstract/Free Full Text]
|
| 40.
|
Jacques, D.,
Dumont, Y.,
Fournier, A.,
and Quirion, R.
(1997)
Neuroscience
79,
129-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Chen, X.,
DiMaggio, D. A.,
Han, S. P.,
and Westfall, T. C.
(1997)
Am. J. Physiol.
273,
H1737-H1744[Abstract/Free Full Text]
|
| 42.
|
Pappas, T. N.,
Debas, H. T.,
and Taylor, I. L.
(1986)
J. Clin. Invest.
77,
49-53
|
| 43.
|
Drucker, D. J.
(1997)
Am. J. Physiol.
273,
G3-G6[Free Full Text]
|
| 44.
|
Dauca, M.,
Bouziges, F.,
Colin, S.,
Kedinger, M.,
Keller, M. K.,
Schilt, J.,
Simon-Assmann, P.,
and Haffen, K.
(1990)
Int. J. Dev. Biol.
34,
205-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
MacKerell, A. D., Jr.
(1988)
J. Comput. Aided Mol. Des.
2,
55-63[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Lundberg, J. M.,
and Tatemoto, K.
(1982)
Acta Physiol. Scand.
116,
393-402[Medline]
[Order article via Infotrieve]
|
| 47.
|
Corr, L. A.,
Aberdeen, J. A.,
Milner, P.,
Lincoln, J.,
and Burnstock, G.
(1990)
Circ. Res.
66,
1602-1609[Abstract/Free Full Text]
|
| 48.
|
Zukowska-Grojec, Z.,
and Wahlestedt, C.
(1993)
in
The Biology of Neuropeptide Y and Related Peptides
(Colmers, W. F.
, and Wahlestedt, C., eds)
, Humana Press, Totowa, NJ
|
| 49.
|
O'Donohue, T. L.,
Chronwall, B. M.,
Pruss, R. M.,
Mezey, E.,
Kiss, J. Z.,
Eiden, L. E.,
Massari, V. J.,
Tessel, R. E.,
Pickel, V. M.,
DiMaggio, D. A.,
Hotchkiss, A. J.,
Crowley, W. R.,
and Zukowska-Grojec, Z.
(1985)
Peptides
6,
755-768[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
McDonald, J. K.
(1988)
Crit. Rev. Neurobiol.
4,
97-135[Medline]
[Order article via Infotrieve]
|
| 51.
|
Ridley, A. J.,
Paterson, H. F.,
Johnston, C. L.,
Diekmann, D.,
and Hall, A.
(1992)
Cell
70,
401-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Ridley, A. J.,
and Hall, A.
(1992)
Cell
70,
389-399[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Kuroda, S.,
Fukata, M.,
Fujii, K.,
Nakamura, T.,
Izawa, I.,
and Kaibuchi, K.
(1997)
Biochem. Biophys. Res. Commun.
240,
430-435[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Ridley, A. J.,
Comoglio, P. M.,
and Hall, A.
(1995)
Mol. Cell. Biol.
15,
1110-1122[Abstract]
|
| 55.
|
Schwartz, M. A.,
Schaller, M. D.,
and Ginsberg, M. H.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
549-599[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Richardson, A.,
and Parsons, J. T.
(1995)
BioEssays
17,
229-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Berton, G.,
Laudanna, C.,
Sorio, C.,
and Rossi, F.
(1992)
J. Cell Biol.
116,
1007-1017[Abstract/Free Full Text]
|
| 58.
|
Oren, R.,
Takahashi, S.,
Doss, C.,
Levy, R.,
and Levy, S.
(1990)
Mol. Cell. Biol.
10,
4007-4015[Abstract/Free Full Text]
|
| 59.
|
Classon, B. J.,
Williams, A. F.,
Willis, A. C.,
Seed, B.,
and Stamenkovic, I.
(1990)
J. Exp. Med.
172,
1007[Free Full Text]
|
| 60.
|
Metzelaar, M. J.,
Wijngaard, P. L.,
Peters, P. J.,
Sixma, J. J.,
Nieuwenhuis, H. K.,
and Clevers, H. C.
(1991)
J. Biol. Chem.
266,
3239-3245[Abstract/Free Full Text]
|
| 61.
|
Peters, P. J.,
Neefjes, J. J.,
Oorschot, V.,
Ploegh, H. L.,
and Geuze, H. J.
(1991)
Nature
349,
669-676[CrossRef][Medline]
[Order article via Infotrieve]
|
| 62.
|
Vischer, U. M.,
and Wagner, D. D.
(1993)
Blood
82,
1184-1191[Abstract/Free Full Text]
|
| 63.
|
Nishibori, M.,
Cham, B.,
McNicol, A.,
Shalev, A.,
Jain, N.,
and Gerrard, J. M.
(1993)
J. Clin. Invest.
91,
1775-1782
|
| 64.
|
Wright, M. D.,
and Tomlinson, M. G.
(1994)
Immunol. Today
15,
588-594[CrossRef][Medline]
[Order article via Infotrieve]
|
| 65.
|
Berditchevski, F.,
Bazzoni, G.,
and Hemler, M. E.
(1995)
J. Biol. Chem.
270,
17784-17790[Abstract/Free Full Text]
|
| 66.
|
Rubinstein, E.,
Le Naour, F.,
Billard, M.,
Prenant, M.,
and Boucheix, C.
(1994)
Eur. J. Immunol.
24,
3005-3013[Medline]
[Order article via Infotrieve]
|
| 67.
|
Berditchevski, F.,
Zutter, M. M.,
and Hemler, M. E.
(1996)
Mol. Biol. Cell
7,
193-207[Abstract]
|
| 68.
|
Shaw, A. R.,
Domanska, A.,
Mak, A.,
Gilchrist, A.,
Dobler, K.,
Visser, L.,
Poppema, S.,
Fliegel, L.,
Letarte, M.,
and Willett, B. J.
(1995)
J. Biol. Chem.
270,
24092-24099[Abstract/Free Full Text]
|
| 69.
|
Peters, P. J.,
Borst, J.,
Oorschot, V.,
Fukuda, M.,
Krahenbuhl, O.,
Tschopp, J.,
Slot, J. W.,
and Geuze, H. J.
(1991)
J. Exp. Med.
173,
1099-1109[Abstract/Free Full Text]
|
| 70.
|
Kuijpers, T. W.,
Tool, A. T.,
van der Schoot, C. E.,
Ginsel, L. A.,
Onderwater, J. J.,
Roos, D.,
and Verhoeven, A. J.
(1991)
Blood
78,
1105-1111[Abstract/Free Full Text]
|
| 71.
|
Knol, E. F.,
Mul, F. P.,
Jansen, H.,
Calafat, J.,
and Roos, D.
(1991)
J. Allergy Clin. Immunol.
88,
328-338[CrossRef][Medline]
[Order article via Infotrieve]
|
| 72.
|
Zukowska-Grojec, Z.,
Karwatowska-Prokopczuk, E.,
Rose, W.,
Rone, J.,
Movafagh, S.,
Ji, H.,
Yeh, Y.,
Chen, W. T.,
Kleinman, H. K.,
Grouzmann, E.,
and Grant, D. S.
(1998)
Circ. Res.
83,
187-195[Abstract/Free Full Text]
|
| 73.
|
Laburthe, M.
(1990)
Trends Endocrinol. Metab.
1,
168-174
|
| 74.
|
Wahlestedt, C.,
Grundemar, L.,
Hakanson, R.,
Heilig, M.,
Shen, G. H.,
Zukowska-Grojec, Z.,
and Reis, D. J.
(1990)
Ann. N. Y. Acad. Sci.
611,
7-26[Medline]
[Order article via Infotrieve]
|
| 75.
|
Pheng, L. H.,
and Regoli, D.
(1998)
Regul. Pept.
75,
79-87
|
| 76.
|
Blomqvist, A. G.,
and Herzog, H.
(1997)
Trends Neurosci.
20,
294-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 77.
|
Feletou, M.,
Rodriguez, M.,
Beauverger, P.,
Germain, M.,
Imbert, J.,
Dromaint, S.,
Macia, C.,
Bourrienne, A.,
Henlin, J. M.,
Nicolas, J. P.,
Boutin, J. A.,
Galizzi, J. P.,
Fauchere, J. L.,
Canet, E.,
and Duhault, J.
(1998)
Regul. Pept.
75,
221-229
|
| 78.
|
Shigeri, Y.,
and Fujimoto, M.
(1994)
J. Biol. Chem.
269,
8842-8848[Abstract/Free Full Text]
|
| 79.
|
Cox, H. M.,
Tough, I. R.,
Ingenhoven, N.,
and Beck-Sickinger, A. G.
(1998)
Regul. Pept.
75,
3-8
|
| 80.
|
Yan, H.,
Yang, J.,
Marasco, J.,
Yamaguchi, K.,
Brenner, S.,
Collins, F.,
and Karbon, W.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
4661-4665[Abstract/Free Full Text]
|
| 81.
|
Gregor, P.,
Millham, M. L.,
Feng, Y.,
DeCarr, L. B.,
McCaleb, M. L.,
and Cornfield, L. J.
(1996)
FEBS Lett.
381,
58-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 82.
|
Hu, Y.,
Bloomquist, B. T.,
Cornfield, L. J.,
DeCarr, L. B.,
Flores-Riveros, J. R.,
Friedman, L.,
Jiang, P.,
Lewis-Higgins, L.,
Sadlowski, Y.,
Schaefer, J.,
Velazquez, N.,
and McCaleb, M. L.
(1996)
J. Biol. Chem.
271,
26315-26319[Abstract/Free Full Text]
|
| 83.
|
Weinberg, D. H.,
Sirinathsinghji, D. J.,
Tan, C. P.,
Shiao, L. L.,
Morin, N.,
Rigby, M. R.,
Heavens, R. H.,
Rapoport, D. R.,
Bayne, M. L.,
Cascieri, M. A.,
Strader, C. D.,
Linemeyer, D. L.,
and MacNeil, D. J.
(1996)
J. Biol. Chem.
271,
16435-16438[Abstract/Free Full Text]
|
| 84.
|
Goumain, M.,
Voisin, T.,
Lorinet, A. M.,
and Laburthe, M.
(1998)
Biochem. Biophys. Res. Commun.
247,
52-56[CrossRef][Medline]
[Order article via Infotrieve]
|
| 85.
|
Jackerott, M.,
and Larsson, L. I.
(1997)
J. Histochem. Cytochem.
45,
1643-1650[Abstract/Free Full Text]
|
| 86.
|
Lee, C. C.,
and Miller, R. J.
(1998)
Regul. Pept.
75,
71-78
|
| 87.
|
Laburthe, M.,
Chenut, B.,
Rouyer-Fessard, C.,
Tatemoto, K.,
Couvineau, A.,
Servin, A.,
and Amiranoff, B.
(1986)
Endocrinology
118,
1910-1917[Abstract/Free Full Text]
|
| 88.
|
Castan, I.,
Valet, P.,
Voisin, T.,
Quideau, N.,
Laburthe, M.,
and Lafontan, M.
(1992)
Endocrinology
131,
1970-1976[Abstract/Free Full Text]
|
| 89.
|
Kitani, S.,
Berenstein, E.,
Mergenhagen, S.,
Tempst, P.,
and Siraganian, R. P.
(1991)
J. Biol. Chem.
266,
1903-1909[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Stanic, G. Paratcha, F. Ledda, H. Herzog, A. S. Kopin, and T. Hokfelt
Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain
PNAS,
March 4, 2008;
105(9):
3610 - 3615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lee, M. Hadi, G. Hallden, and G. W. Aponte
Peptide YY and Neuropeptide Y Induce Villin Expression, Reduce Adhesion, and Enhance Migration in Small Intestinal Cells through the Regulation of CD63, Matrix Metalloproteinase-3, and Cdc42 Activity
J. Biol. Chem.,
January 7, 2005;
280(1):
125 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lo, W. Tynan, J. Dickerson, M. Scharf, J. Cooper, D. Byrne, D. Brayden, L. Higgins, C. Evans, and D. J. O'Mahony
Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures
Int. Immunol.,
January 1, 2004;
16(1):
91 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|